FOCL · Edap Tms SA
$6.24
+0.18 (+2.97%)
At close · Jul 29
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company may need to raise substantial additional financing in order to meet its cash flow needs in the subsequent period and until it achieves profitability. The Company may not be able to raise additional financing on acceptable terms or at all and this condition may in the future raise uncertainty regarding its ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$234.26M
Shares
37.48M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$70.53M
+10%
FY2025
Net Income
-$29.25M
-42.1%
FY2025
Gross Margin
42.54%
+1.1pp
FY2025
Operating Margin
-35.01%
-3pp
FY2025
Diluted EPS
-$0.78
-52.9%
FY2025
Operating Cash Flow
-$16.41M
-20.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $50M – $54M | $70.53M | $64.11M | $60.42M | $55.11M | $44.07M | $41.66M | $44.91M | $39.18M | $35.75M | $35.61M | $32.25M | $26.79M | $24.08M | $26.07M | $22.29M | |
| EUR | — | — | — | 1.08M | 236K | 145K | -98K | -146K | 797K | 2.64M | 3.95M | -2.09M | — | — | — | — |
| — | $40.53M | $37.56M | $36.01M | $30.92M | $25.64M | $23.28M | $23.91M | $22.27M | $20.94M | $19.2M | $18.47M | $15.58M | $14.76M | $15.63M | $13.44M | |
| — | $30M | $26.56M | $24.41M | $24.19M | $18.42M | $18.38M | $21M | $16.92M | $14.81M | $16.41M | $13.79M | $11.2M | $9.32M | $10.43M | $8.86M | |
| — | 42.54% | 41.42% | 40.4% | 43.9% | 41.81% | 44.11% | 46.76% | 43.17% | 41.43% | 46.08% | 42.74% | 41.82% | 38.7% | 40.03% | 39.73% | |
| — | $9.66M | $7.73M | $6.96M | $4.92M | $3.4M | $4.5M | $3.73M | $4.09M | $3.88M | $3.87M | $2.69M | $2.93M | $2.6M | $2.66M | $2.44M | |
| — | $27.32M | $25.28M | $22.63M | $16.38M | $10.73M | $9.28M | $10.85M | $10.55M | $9.53M | $8.86M | $7.41M | $6.68M | $6.28M | $6.62M | $5.87M | |
| — | $17.72M | $14.08M | $14.63M | $7.15M | $5.9M | $4.34M | $4.22M | $3.59M | $3.43M | $3.3M | $3.2M | $3.33M | $3.2M | $3.19M | $3.04M | |
| — | $304K | $220K | $175K | $141K | $125K | $113K | $113K | $110K | $74K | $42K | $6000 | $26K | $32K | $36K | — | |
| — | $3.41M | $2.57M | $1.91M | $1.61M | $1.92M | $2.11M | $1.88M | $1.61M | $1.57M | $1.03M | $1M | $900K | $1.18M | $931K | $1.41M | |
| — | $54.7M | $47.09M | $44.22M | — | — | — | — | — | $16.84M | $16.02M | -$13.3M | — | — | -$12.46M | — | |
| — | -$24.69M | -$20.53M | -$19.81M | -$4.26M | -$1.61M | $269K | $2.2M | -$1.32M | -$2.03M | $392K | $488K | -$1.74M | -$2.76M | -$2.03M | -$2.5M | |
| — | -35.01% | -32.03% | -32.79% | -7.72% | -3.66% | 0.65% | 4.9% | -3.36% | -5.67% | 1.1% | 1.51% | -6.48% | -11.44% | -7.79% | -11.2% | |
| — | -$21.29M | -$17.97M | -$17.9M | -$2.65M | $308K | $2.37M | $4.08M | $295K | -$454K | $1.42M | $1.49M | -$836K | -$1.58M | -$1.1M | -$1.08M | |
| — | $789K | $236K | $232K | $168K | $52K | $108K | $165K | $111K | $44K | $57K | $64K | -$65K | -$1.97M | -$2.07M | — | |
| — | $252K | $796K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$28.81M | -$18.73M | -$20.53M | -$2.1M | $893K | -$1.19M | $2.19M | $20K | -$293K | $4.44M | -$907K | -$396K | -$4.89M | -$7.36M | -$543K | |
| — | $438K | $289K | $644K | $837K | $193K | $516K | $679K | $358K | $388K | $602K | $759K | $116K | $135K | $118K | $395K | |
| — | -$29.25M | -$20.58M | -$21.18M | -$2.93M | $699.89K | -$1.7M | $1.51M | -$338K | -$681K | $3.84M | -$1.67M | -$512K | -$5.02M | -$7.48M | -$938K | |
| — | -41.47% | -32.11% | -35.05% | -5.32% | 1.59% | -4.09% | 3.37% | -0.86% | -1.91% | 10.79% | -5.17% | -1.91% | -20.85% | -28.68% | -4.21% | |
| EUR | — | — | — | — | — | — | — | — | -338.38M | -681.35M | 3.84B | -1.67M | -512.01K | -5.02M | -7.48M | — |
| — | -$25.63M | -$19.43M | -$21.84M | -$3.17M | $175K | -$1.33M | $1.83M | -$483K | -$336K | $3.46M | -$2.02M | -$502K | -$4.92M | -$7.21M | -$1.14M | |
| USD/shares | — | -$0.78 | -$0.51 | -$0.57 | -$0.09 | $0.02 | -$0.06 | $0.05 | -$0.01 | -$0.02 | $0.14 | -$0.07 | -$0.02 | -$0.24 | -$0.43 | — |
| USD/shares | — | -$0.78 | -$0.51 | -$0.57 | -$0.09 | $0.02 | -$0.06 | $0.05 | -$0.01 | -$0.02 | $0.13 | -$0.07 | -$0.02 | -$0.24 | -$0.43 | — |
| shares | — | 37.44M | 37.29M | 37M | 34.39M | 32.13M | 29.15M | 29.02M | 29M | 28.96M | 27.82M | 25.02M | 23.6M | 20.59M | 17.56M | 13.35M |
| shares | — | 37.44M | 37.29M | 37M | 34.39M | 32.42M | 29.15M | 29.62M | 29M | 28.96M | 29.37M | 25.02M | 23.6M | 20.59M | 17.56M | 13.35M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Medical Distribution median 24.49×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| High Intensity Focused Ultrasound HIFU | $37,351,000 | $25,803,000 |
| Distribution Division | $25,712,000 | $33,871,000 |
| Lithotripsy Eswl | $7,463,000 | $9,722,000 |
By Geography (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| United States | $28,525,000 | $19,721,000 |
| Asia | $19,567,000 | $20,610,000 |
| Other Geographical Areas | $17,845,000 | $16,898,000 |
| France | $4,589,000 | $12,166,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Manufactured Product Other | $48,896,000 | $47,664,000 |
| Parts and Services | $11,342,000 | $13,495,000 |
| HIFU Treatments and Devices Leased | $10,289,000 | $8,237,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Lithotripsy Eswl | $2,099,000 | $1,310,000 |
| Distribution Division | -$809,000 | -$618,000 |
| High Intensity Focused Ultrasound HIFU | -$20,679,000 | -$18,897,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 |
|---|---|---|
| High Intensity Focused Ultrasound HIFU | -55.4% | -73.2% |
| Distribution Division | -3.1% | -1.8% |
| Lithotripsy Eswl | 28.1% | 13.5% |